Klinika Chirurgii Naczyniowej, Wewnątrznaczyniowej, Angiologii i Flebologii, Instytut Chirurgii, Uniwersytet Medyczny w Poznaniu.
Katedra i Klinika Okulistyki, Uniwersytet Medyczny w Poznaniu.
Pol Przegl Chir. 2021 Apr 27;93(2):43-52. doi: 10.5604/01.3001.0014.8500.
The current limitations of surgical treatment, as well as restrictions on professional and sport activities related to COVID-19 pandemic require seeking therapeutic solutions for the vast population of patients with chronic venous insufficiency (CVI, chronic venous insufficiency). To understand the principles of pharmacotherapy of this disease, the authors used data related to epidemiology and pathophysiology of CVI. They provided the latest data on venoactive drugs and recommendations that should be followed and summarized the literature based on the EBM. The article should provide the answer to the question of how to deal with patients with varicose veins or, more broadly, chronic venous insufficiency during the pandemic.
当前，手术治疗存在局限性，同时受到与 COVID-19 大流行相关的职业和体育活动限制的影响，这就需要为广大慢性静脉功能不全（CVI，chronic venous insufficiency）患者寻找治疗方法。为了了解这种疾病的药物治疗原则，作者使用了与 CVI 的流行病学和病理生理学相关的数据。他们提供了关于静脉活性药物的最新数据以及应该遵循的建议，并根据循证医学对文献进行了总结。本文应该能够回答在大流行期间如何处理静脉曲张患者或更广泛地说，如何处理慢性静脉功能不全患者的问题。
